PFA Pension Forsikringsaktieselskab acquired a new position in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 9,492 shares of the company's stock, valued at approximately $1,911,000.
Several other hedge funds and other institutional investors have also recently bought and sold shares of THC. Wedmont Private Capital grew its stake in shares of Tenet Healthcare by 2.5% during the 4th quarter. Wedmont Private Capital now owns 2,088 shares of the company's stock valued at $422,000 after buying an additional 50 shares during the period. Baron Wealth Management LLC grew its stake in shares of Tenet Healthcare by 4.8% during the 4th quarter. Baron Wealth Management LLC now owns 1,142 shares of the company's stock valued at $227,000 after buying an additional 52 shares during the period. Sagespring Wealth Partners LLC grew its stake in shares of Tenet Healthcare by 3.6% during the 4th quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company's stock valued at $313,000 after buying an additional 55 shares during the period. Crestwood Advisors Group LLC lifted its holdings in shares of Tenet Healthcare by 2.5% during the 3rd quarter. Crestwood Advisors Group LLC now owns 2,606 shares of the company's stock valued at $529,000 after acquiring an additional 64 shares in the last quarter. Finally, Signaturefd LLC lifted its holdings in shares of Tenet Healthcare by 9.0% during the 4th quarter. Signaturefd LLC now owns 798 shares of the company's stock valued at $159,000 after acquiring an additional 66 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts recently weighed in on the stock. Jefferies Financial Group lifted their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a "buy" rating in a report on Thursday, February 12th. Stephens reduced their target price on shares of Tenet Healthcare from $275.00 to $260.00 and set an "overweight" rating on the stock in a report on Monday. KeyCorp reduced their target price on shares of Tenet Healthcare from $250.00 to $225.00 and set an "overweight" rating on the stock in a report on Friday. Barclays lifted their target price on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a report on Friday, February 13th. Finally, Truist Financial lifted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a "buy" rating in a report on Tuesday, February 17th. Nineteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Tenet Healthcare has a consensus rating of "Moderate Buy" and a consensus price target of $242.89.
Check Out Our Latest Stock Report on Tenet Healthcare
Insider Activity
In other Tenet Healthcare news, insider R. Scott Ramsey sold 8,017 shares of the company's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Thomas W. Arnst sold 8,000 shares of the company's stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the transaction, the executive vice president owned 12 shares of the company's stock, valued at approximately $2,866.20. This trade represents a 99.85% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is currently owned by corporate insiders.
Tenet Healthcare Stock Performance
Shares of THC stock opened at $185.24 on Tuesday. Tenet Healthcare Corporation has a 12 month low of $146.31 and a 12 month high of $247.21. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.36 and a quick ratio of 1.30. The firm has a market capitalization of $16.23 billion, a P/E ratio of 9.63, a P/E/G ratio of 1.37 and a beta of 1.30. The company's fifty day moving average price is $207.31 and its two-hundred day moving average price is $204.33.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts' consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The firm had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the business posted $4.36 EPS. The firm's revenue was up 2.6% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, research analysts anticipate that Tenet Healthcare Corporation will post 17.42 earnings per share for the current fiscal year.
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.
In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.
Read More
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.